KIORA PHARMACEUTICALS, INC. Proceeds from Lines of Credit
KIORA PHARMACEUTICALS, INC. (KPRX) reported Proceeds from Lines of Credit of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for the quarter ending 2025-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for the quarter ending 2025-09-30 was $1.75M.
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for the quarter ending 2024-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for the quarter ending 2024-09-30 was $0.00.
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for fiscal 2025 was $2.75M.
- KIORA PHARMACEUTICALS, INC. proceeds from lines of credit for fiscal 2024 was $0.00.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-07 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.75M derived: sum of 2 quarters · filed 2026-03-25 | $2.75M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.75M 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | $1.00M 10-Q · filed 2026-08-07 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |